These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8883149)

  • 1. Viral pathogenesis in hu-PBL-SCID mice.
    Mosier DE
    Semin Immunol; 1996 Aug; 8(4):255-62. PubMed ID: 8883149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
    Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
    Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
    Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
    AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
    Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
    Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenogeneic PBL-scid mice: their potential and current limitations.
    Greenwood JD
    Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.
    Jamieson BD; Aldrovandi GM; Zack JA
    Semin Immunol; 1996 Aug; 8(4):215-21. PubMed ID: 8883144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K; Tanaka R; Ogura T; Ito M; Kumakura S; Yanaka M; Nishizawa M; Sugiura W; Yamamoto N; Tanaka Y
    J Infect Dis; 2008 Jan; 197(1):134-41. PubMed ID: 18171296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and applications of the SCID-hu mouse model.
    McCune JM
    Semin Immunol; 1996 Aug; 8(4):187-96. PubMed ID: 8883141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.
    Garaci E; Aquaro S; Lapenta C; Amendola A; Spada M; Covaceuszach S; Perno CF; Belardelli F
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8927-32. PubMed ID: 12853577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
    Koup RA; Safrit JT; Weir R; Gauduin MC
    Semin Immunol; 1996 Aug; 8(4):263-8. PubMed ID: 8883150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
    Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
    J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
    Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
    Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer.
    Khatri VP; Baiocchi RA; Bernstein ZP; Caligiuri MA
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S129-36. PubMed ID: 9457408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Model of B immunoblastic lymphomas in the Hu-PBL-SCID mice].
    Chen DQ; Bai LJ; Liu QF; Cui LX; He W; Ba DN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):294-6. PubMed ID: 12905742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.